Pubdate: Mon, 23 Feb 2015 Source: Chicago Sun-Times (IL) Copyright: 2015 Sun-Times Media, LLC Contact: http://mapinc.org/url/5QwXAJWY Website: http://www.suntimes.com/ Details: http://www.mapinc.org/media/81 Author: Becky Schlikerman DOCS INVESTING IN POT It's OK for Illinois Physicians to Get into the Medical Marijuana Business- As Long As They Don't Recommend It to Patients At least three Illinois doctors are getting into the legal medical marijuana business, according to a review of records of the companies recently approved to grow and sell marijuana. The rules say that's OK as long as they don't recommend marijuana to their patients. But physicians' involvement in the medical marijuana industry raises questions about the potential for conflicts of interest. "We don't like doctors prescribing or directing patients to taking therapies they're making money on," said Laurie Zoloth a professor of bioethics at Northwestern University Feinberg School of Medicine. But, it's not "inherently wrong" for doctors to be involved in this burgeoning field, she said. Their medical knowledge could be useful. "It's not a bad thing for doctors to be involved . . . you just want it to be separated," Zoloth said. Katherine Katsoyannis, a licensed Illinois doctor, is an investor in MedMar and MedMar Rockford, which has been awarded licenses to open dispensaries in Lake View and northern Illinois. In a statement released through a spokeswoman, Katsoyannis said she is "simply an investor" and will not be recommending patients to use the product. Katsoyannis owns 10.21 percent of MedMar, the company that plans to open the Chicago dispensary, records obtained through a Freedom of Information Act request show. On Friday, MedMar was denied a Chicago permit needed to operate the dispensary. A state spokesman did not respond to questions about what that means for MedMar's state permit. Mapleglen Care Center LLC was also given permission to open in the Rockford area. The company's listed manager is Paul L. Manganelli, of Naperville. He's also a doctor, with a specialty in pain medicine, working in DuPage County, according to state records and his medical practice's website. Manganelli, an investor with Mapleglen, could not be reached. In a statement, Matt Sobolewski, a Mapleglen spokesman and investor, said, "Our investorship is made up of a diverse group of professionals including physicians, attorneys and business owners. We see great value with physician participation in medical marijuana dispensaries as their experience in evidence-based medicine makes them best qualified to provide education and training to care center staff and patients." And Progressive Treatment Solutions LLC has been granted a permit to grow medical marijuana in the area near East St. Louis, records show. Records show Christine Heck is the company's CEO. Online company documents identify Heck as a podiatric physician and surgeon who practices in Chicago and Melrose Park. Heck and other company officials did not respond to a request for comment, but their online document described the company as "medically focused." "Products and services provided by PTS will be condition specific and based on the most advanced research presently available," the document said. The company says it will produce products that won't require smoking the marijuana including vaporizers, transdermal patches, tablets, capsules, suppositories and topical products. A state spokesman said regulators who awarded the business licenses relied on the clear-cut rules for medical marijuana dispensaries and cultivation centers. A dispensary can't "allow a physician to hold a direct or indirect economic interest in the dispensary if the physician recommends the use of medical cannabis to qualifying patients or is in a partnership or other fee or profit-sharing relationship with a physician who recommends medical cannabis." Doctors can't examine a patient at the dispensary in order to diagnose a condition that would allow for the use of medical marijuana. The law also says doctors can't serve on a dispensary or cultivation center's board of directors or as an employee. Katsoyannis said she won't be be violating any of those requirements. The Mapleglen spokesman said they know the requirements, too. The boundaries are important. "We want to trust that the doctor is figuring out the complexity of the illness and he's not thinking of you as a potential customer for his product," Zoloth said. - --- MAP posted-by: Jay Bergstrom